459,53 €
510,59 €
-10% with code: EXTRA
Metalloproteinases as Targets for Anti-Inflammatory Drugs
Metalloproteinases as Targets for Anti-Inflammatory Drugs
459,53
510,59 €
  • We will send in 10–14 business days.
This volume describes recent research in the field of metalloproteinases (a family of enzymes that can catalyze tissue degradation), in particular their participation in autoimmune diseases such as rheumatoid arthritis, reviewing the latest developments in metalloproteinase inhibitor design and the current status of clinical candidates. This volume is intended not only for those active in research into metalloproteinases but also for those with an interest in inflammatory diseases. Thus it addr…
  • Publisher:
  • Year: 2012
  • Pages: 207
  • ISBN-10: 3034897243
  • ISBN-13: 9783034897242
  • Format: 15.6 x 23.4 x 1.2 cm, softcover
  • Language: English
  • SAVE -10% with code: EXTRA

Metalloproteinases as Targets for Anti-Inflammatory Drugs (e-book) (used book) | bookbook.eu

Reviews

Description

This volume describes recent research in the field of metalloproteinases (a family of enzymes that can catalyze tissue degradation), in particular their participation in autoimmune diseases such as rheumatoid arthritis, reviewing the latest developments in metalloproteinase inhibitor design and the current status of clinical candidates. This volume is intended not only for those active in research into metalloproteinases but also for those with an interest in inflammatory diseases. Thus it addresses both academic and industrial researchers.

EXTRA 10 % discount with code: EXTRA

459,53
510,59 €
We will send in 10–14 business days.

The promotion ends in 20d.22:54:00

The discount code is valid when purchasing from 10 €. Discounts do not stack.

Log in and for this item
you will receive 5,11 Book Euros!?
  • Publisher:
  • Year: 2012
  • Pages: 207
  • ISBN-10: 3034897243
  • ISBN-13: 9783034897242
  • Format: 15.6 x 23.4 x 1.2 cm, softcover
  • Language: English English

This volume describes recent research in the field of metalloproteinases (a family of enzymes that can catalyze tissue degradation), in particular their participation in autoimmune diseases such as rheumatoid arthritis, reviewing the latest developments in metalloproteinase inhibitor design and the current status of clinical candidates. This volume is intended not only for those active in research into metalloproteinases but also for those with an interest in inflammatory diseases. Thus it addresses both academic and industrial researchers.

Reviews

  • No reviews
0 customers have rated this item.
5
0%
4
0%
3
0%
2
0%
1
0%
(will not be displayed)